VX1.DEVX1.DEXETRA
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank21
5Y CAGR-4.4%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

5Y CAGR
-4.4%/yr
Long-term compound
Percentile
P21
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
20253.41%
2024-1.62%
202345.26%
2022-16.74%
202166.77%
20204.27%
201923.87%
20186.93%
201726.43%
20165.17%